MB, Levis & Associates’s iShares iBonds Dec 2030 Term Corporate ETF IBDV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-603,760
Closed -$13.3M 274
2025
Q2
$13.3M Buy
603,760
+9,890
+2% +$214K 5.83% 7
2025
Q1
$12.9M Buy
593,870
+3,912
+0.7% +$84.1K 5.99% 7
2024
Q4
$12.6M Buy
589,958
+8,010
+1% +$173K 6.31% 6
2024
Q3
$12.9M Buy
581,948
+8,299
+1% +$181K 6.36% 6
2024
Q2
$12.2M Buy
573,649
+14,432
+3% +$305K 6.41% 6
2024
Q1
$12M Buy
559,217
+12,153
+2% +$260K 6.43% 6
2023
Q4
$11.8M Buy
547,064
+27,124
+5% +$561K 6.77% 6
2023
Q3
$10.6M Buy
519,940
+5,043
+1% +$105K 6.87% 6
2023
Q2
$10.9M Buy
514,897
+79,850
+18% +$1.7M 6.99% 5
2023
Q1
$9.37M Buy
435,047
+40,350
+10% +$858K 6.52% 5
2022
Q4
$8.21M Buy
+394,697
New +$8.14M 6.42% 5

Other funds holding IBDV

MB, Levis & Associates's IBDV Position: Q3 2025 in Review

MB, Levis & Associates sold out of iShares iBonds Dec 2030 Term Corporate ETF (IBDV) in Q3 2025, closing a stake of 603,760 shares — an estimated $13.3M sold.

MB, Levis & Associates first reported a position in IBDV in Q4 2022 and held it in 11 quarters. The position peaked at $13.3M in Q2 2025. 268 funds tracked by Wall St. Rank hold IBDV as of Q3 2025.

  • MB, Levis & Associates reported no remaining iShares iBonds Dec 2030 Term Corporate ETF position as of Q3 2025 after selling out during the quarter.
  • MB, Levis & Associates sold 603,760 iShares iBonds Dec 2030 Term Corporate ETF shares in Q3 2025, an estimated $13.3M.
  • MB, Levis & Associates first reported a position in iShares iBonds Dec 2030 Term Corporate ETF in Q4 2022 and held it in 11 quarters.
  • MB, Levis & Associates's iShares iBonds Dec 2030 Term Corporate ETF position peaked at $13.3M in Q2 2025.
  • 268 funds tracked by Wall St. Rank held iShares iBonds Dec 2030 Term Corporate ETF as of Q3 2025.

Based on MB, Levis & Associates's 13F filing for Q3 2025, filed 15 Oct 2025.